Search Results

1 - 10 of 38 items :

Clear All

with an electronic portal imaging device (EPID) for 115 prostate cancer patients. Int J Radiat Oncol Biol Phys. 1999;45(5):1297-1303. [5] Kroonwijk M, Pasma KL, Quint S, et al. In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion. Radiother Oncol. 1998;49(2):125-132. [6] Huyskens D, Van Dam J, Dutreix A. Midplane dose determination using in vivo dose measurements in combination with portal imaging. Phys Med Biol. 1994;39(7):1089-1101. [7] Woźniak B, Ganowicz M, Bekman A, Maniakowski Z

, Pistorius S. Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device. Med.Phys. 2001;28(6):911-924. [11] Winkler P, Hefner A, Georg D. Dose-response characteristics of an amorphous silicon EPID. Med Phys. 2005;32(10):3095-3105. [12] Camilleri J, Mazurier J, Franck D, et.al. Clinical results of an EPID-based in- vivo dosimetry method for pelvic cancers treated by intenstity modulated radio therapy. Phys Med. 2014;30(6):690-695. [13] Huyskens D, Van Dam J, Dutreix A. Mid plane dose determination using in

; 2002. Brady LW, Heilmann HP, Molls M. New technologies in radiation oncology. Springer Verlag Berlin Heidelberg; 2006. PortalVision Users Guide: Reference Manual for aS500 PortalVision. Palo Alto: Varian Medical Systems; 2003. Berger L, Francois P, Gaboriaud G, Rosenvald JC. Performance optimization of the Varian aS500 EPID system. J Appl Clin Med Phys 2006; 7: 105-114. Greer PB, Barnes MP. Investigation of an amorphous silicon EPID for measurement and quality assurance of enhanced dynamic wedge. Phys Med Biol 2007; 10: 1075-87. Menon GV, Sloboda RS

Y, Araki F, Tominaga H, et al. Angular dependence correction of MatriXX and its application to composite dose verification. J Appl Clin Med Phys. 2012;13(5):81-96. [18] Boggula R, Birkner M, Lohr F, et al. Evaluation of a 2D detector array for patient-specific VMAT QA with different setups. Phys Med Biol. 2011l56(22):7163-7177. [19] Bakhtiari M, Kumaraswamy L, Bailey DW, et al. Using an EPID for patient-specific VMAT quality assurance Using an EPID for patient-specific VMAT quality assurance. Med Phys. 2011;38(3):1366-73. [20] Iori M, Cagni E, Paiusco M, et al

EPID-based QA for IMRT. J Appl Clin Med Phys 2008; 9: 16-25. Pasma KL, Dirkx MLP, Kroonwijk M, Visser AG, Heijmen BJM. Dosimetric verification of intensity modulated beams produced with dynamic multileaf collimation using an electronic portal imaging device. Med Phys 1999; 26: 2373-8. Talamonti C, Casati M, Bucciolini M. Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID. Med Phys 2006; 33: 4367-78. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification

References Boyer AL, Antomuk L, Fenster A, Van Herk M, Meertens H, Munro P, et al. A review of electronic portal imaging devices (EPIDs). Med Phys 1992; 19 : 1-16. Langmack K A, Phil D. Portal imaging. Brit J Radiol 2001; 74 : 789-804. Whittington R, Bloch P, Hutchinson D, Björrngard BE. Verification of prostate treatment setup using computed radiography for portal imaging. J Appl Clin Med Physi 2002; 3 : 88-96. Johnson LS, Milliken BD, Hodley SW, Pelizzari CA, Haraf DJ, Chen GTY. Initial clinical experience with a video-based patient positioning system

, Chan MF, Jarry G, et al. Evaluating IMRT and VMAT dose accuracy: Practical examples of failure to detect systematic errors when applying a commonly used metric and action levels. Med Phys. 2013;40(11):111722. [5] Mans A, Remeijer P, Olaciregui-Ruiz I, , et al. 3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry. Radiother Oncol. 2010;94(2):181-187. [6] Bailey DW, Kumaraswamy L, Bakhtiari M, et al. EPID dosimetry for pretreatment quality assurance with two commercial systems. J Appl Clin Med Phys. 2012;13(4):82-99. [7] Greer PB. 3D EPID

: Chorological analysis of the algal flora of “Su Gologone” spring in Sardinia. Proceedings of the International Symposium on Biogeographical Aspects of Insularity, Rome, 417-427. Dell’Uomo, A., 2004: L’indice diatomico di eutrofi zzazione/polluzione (EPI-D) nel monitoraggio delle acque correnti. Linee Guida. Agenzia per la Protezione dell’Ambiente e per i servizi Tecnici, Rome. Dell’Uomo, A., Torrisi M., 2000: Diatomées de sources et diatomées d’embouchures dans les cours d’eau de l’Apenin central (Italie). Cryptogamie Algologie 21, 247-248. Dell’Uomo, A., Torrisi, M., 2001

IMRT subcommittee of the AAPM radiation therapy committee. Med Phys 2003; 30: 2089. 10. Jursinic PA, Nelms BE. A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery. Med Phys 2003; 30: 870-9. 11. Poppe B, Blechschmidt A, Djouguela A, Kollhoff R, Rubach A, Willborn KC, et al. Two-dimensional ionization chamber arrays for IMRT plan verification. Med Phys 2006; 33: 1005-15. 12. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of

Biological Diatom Index (BDI): Description and efficiency of the new version (BDI-2006). Ecological Indicators 9, 621–650. Dell’Uomo, A., 2004: L’Indice Diatomico de Eutrofizzacione/Polluzione (EPI-D) nel Monitoraggio delle Acque Correnti. Linee Guida. APAT: Roma. Denić, LJ., Čađo, S., Đuraković, A., Novaković, B., Dopuđa-Glišić, T., Veljković, N., Stojanović, Z., Milovanović, J., Domanović, M., 2015: Status of surface waters of Serbia: Analysis and elements for monitoring design. Agencija za zaštitu životne sredine, Ministarstvo poljoprivrede i zaštite životne sredine